Lesanne Life Sciences is a stroke diagnostics company that is developing a proprietary protein biomarker for the rapid diagnosis of CNS ischemia resulting from stroke, transient ischemic attacks ("TIAs"), lacunar infarcts, traumatic brain injury ("TBI"), myocardial infarction, and coronary artery bypass graft ("CABG") surgery.

The Channel Group, a New York-based life sciences venture development and management firm, founded Lesanne in 2006.
 
Lesanne Life Sciences develops diagnostics for the following conditions:
more info>>
more info>>
more info>>